RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Beard, S., von Scheele, BG., Nuki, G., & Pearson, I. (2014). Erratum to: Cost-effectiveness of febuxostat in chronic gout. European Journal of Health Economics, 15(8), 897. https://doi.org/10.1007/s10198-014-0617-1
In the original publication, the size of cohort was incorrectly published as 1,000 patients in the first sentence of the fourth paragraph under heading ‘Methods’. The correct cohort size is “100 patients” and the sentence should read as: “The model was used to consider a cohort of 100 patients who had sUA levels of at least 8 mg/dl (0.48 mmol/l) and who had received a ULT with various treatment sequences”.